How did the world get the Covid-19 vaccine so fast?

How scientists are leveraging artificial intelligence to solve the pandemic

Catriona Campbell
Feb 5 · 3 min read

Since coronavirus first appeared in China, researchers have looked to artificial intelligence for many different answers. In fact, machine learning (ML) systems and computational tools are why we were able to start testing potential vaccines as early as March 2020 — far sooner than humans could ever hope to create one without the help of such technologies.

Why? Because AI technologies allow scientists to rapidly draw insights from vast data sets that previously would have taken huge teams YEARS to analyse. As is the case in so many applications of AI, the best results come from human-machine collaboration — I said as much in a recent Instagram post on using AI to combat fake news.

In terms of Covid-19 vaccine development, ML and computation play their part, but there’s no substitute for human lab work. Many of these collaborations have produced vaccines showing favourable results in phase III clinical trials with several now approved for use across the world.

One of these is the RNA vaccine designed by pharmaceuticals giant Pfizer alongside German biotech firm BioNTech. The BioNTech story is a fascinating one. Married Turkish-German scientists Özlem Türeci and Ugur Sahin set up in Mainz, Germany in 2008, with the aim of developing new types of immunotherapy against cancer. A mere twelve years later, BioNTech is worth over £16 billion and is leading us to the end of the coronavirus era.

After hearing about the Wuhan outbreak, the couple set about their Covid vaccine research project (Project Lightspeed) in January 2020. Sahin, who felt the development of a vaccine was a “duty,” said:

“There are not too many companies on the planet which have the capacity and the competence to do it so fast as we can do it.”

“biology with bioinformatics, robotics and artificial intelligence.”

BioNtech’s recent partnership with London-based InstaDeep suggests the need for even greater expertise in AI. Both firms say:

“The AI innovation lab will combine InstaDeep’s advanced capabilities in the areas of artificial intelligence, machine learning, and digitalization along with BioNTech’s deep domain expertise in precision immunotherapies and its access to a wide variety of internal and external datasets.”

If it helps get us back to some sense of normalcy, I’m all for human-machine collaboration. A final word of warning though: some coronavirus AI systems were applied without first being tested or were trained on small or low-quality data sets. This was possibly justified by the horrors of the pandemic and a life-or-death timeframe, but future regulation of such systems must be tighter or they could do more harm than good!

The Startup

Get smarter at building your thing. Join The Startup’s +724K followers.

The Startup

Get smarter at building your thing. Follow to join The Startup’s +8 million monthly readers & +724K followers.

Catriona Campbell

Written by

Behavioural psychologist; AI-quisitive; EY UK&I Client Technology & Innovation Officer. Views my own & don't represent EY’s position. catrionacampbell.com

The Startup

Get smarter at building your thing. Follow to join The Startup’s +8 million monthly readers & +724K followers.

Medium is an open platform where 170 million readers come to find insightful and dynamic thinking. Here, expert and undiscovered voices alike dive into the heart of any topic and bring new ideas to the surface. Learn more

Follow the writers, publications, and topics that matter to you, and you’ll see them on your homepage and in your inbox. Explore

If you have a story to tell, knowledge to share, or a perspective to offer — welcome home. It’s easy and free to post your thinking on any topic. Write on Medium

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store